Biblio
Incorporation of a Toll-like receptor 2/6 agonist potentiates mRNA vaccines against cancer and infectious diseases. Signal Transduct Target Ther. 2023;8(1):273.
. MUC1 promotes cancer stemness and predicts poor prognosis in osteosarcoma. Pathol Res Pract. 2023;242:154329.
. Comprehensive characterization of stemness-related lncRNAs in triple-negative breast cancer identified a novel prognostic signature related to treatment outcomes, immune landscape analysis and therapeutic guidance: a silico analysis with in vivo experimen. J Transl Med. 2024;22(1):423.
. Heparan sulfate promotes TRAIL-induced tumor cell apoptosis. Elife. 2024;12.
. . .